Applied BioCode Corporation (TPE:6598)
28.40
-0.70 (-2.41%)
Oct 30, 2026, 1:30 PM CST
Applied BioCode Revenue
Applied BioCode had revenue of 210.11M TWD in the quarter ending June 30, 2026, with 81.29% growth. This brings the company's total for the last twelve months to 666.54M, up 68.40% year-over-year. In the year 2025, Applied BioCode had annual revenue of 475.20M with 38.52% growth. That makes Applied BioCode the 33,700th largest company in the world by revenue and 1,750th in Taiwan.
Revenue (ttm)
666.54M
Revenue Growth
+68.40%
P/S Ratio
4.38
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.92B
Revenue by Geography
- United States 433.79M 91.3%
- China 41.42M 8.7%
Fiscal year ended Dec 31, 2025 See the full Applied BioCode breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 475.20M | 132.13M | 38.52% |
| Dec 31, 2024 | 343.07M | -52.10M | -13.18% |
| Dec 31, 2023 | 395.17M | 4.87M | 1.25% |
| Dec 31, 2022 | 390.30M | 70.34M | 21.98% |
| Dec 31, 2021 | 319.96M | 20.95M | 7.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Hi-Clearance | 4.41B |
| Wellell | 2.50B |
| Apex Biotechnology | 1.87B |
| OK Biotech | 1.54B |
| Dynamic Medical Technologies | 1.40B |
| WeLeader Biomedical | 1.21B |
| A Plus Biotechnology | 887.93M |
| Medimaging Integrated Solution | 682.01M |